الفهرس | Only 14 pages are availabe for public view |
Abstract 19 (FGF15 and FGF19 are the mouse and human orthologs, respectively), FGF21, and FGF23, are endocrine factors involved in hormone-like metabolic effects through activation of FGF receptors. FGF19 is mainly produced by the enterocytes in the distal part of the small intestine Aim of the work. This study was planned to evaluate the level of FGF19 in patients with metabolic syndrome (according to new IDF definition) and to clarify the correlation, if any, with all its parameters. Patient and Method. This study included 100 subjects who were classified into two groups. |